Blue Cap AG logo

Blue Cap AG (B7Ed)

Market Open
CBOE CBOE
- Market Cap
- P/E Ratio
2.6% Div Yield
- Volume
3.33 Eps
Want to track B7Ed and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

B7Ed pays dividends to its shareholders, with the most recent payment made on Jun 26, 2026. The next estimated payment will be in 1 month ago on Jun 26, 2026 for a total of €1.6.
The last earnings report, released on May 12, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
Blue Cap AG has completed 1 stock splits, with the recent split occurring on Mar 19, 2007.
The company's stock is traded on 6 different exchanges and in various currencies, with the primary listing on XFRA (EUR).

Blue Cap AG (B7Ed) FAQ

On which exchange is it traded?

Blue Cap AG is listed on CBOE.

What is its stock symbol?

The ticker symbol is B7Ed.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 2.6%.

What is its market cap?

As of today, no market cap data is available.

Has Blue Cap AG ever had a stock split?

Blue Cap AG had 1 splits and the recent split was on Mar 19, 2007.

Blue Cap AG Profile

Capital Markets Industry
Financials Sector
Dr. Henning von Kottwitz CEO
CBOE Exchange
DE000A0JM2M1 ISIN
Germany Country
- Employees
24 Jun 2026 Last Dividend
19 Mar 2007 Last Split
- IPO Date

Overview

Blue Cap AG is a distinguished private equity firm that has carved a niche for itself by specializing in a range of investment activities targeting the middle market. With an emphasis on late stage, mature, turnaround, recapitalization, buyout, and growth capital investments, Blue Cap AG demonstrates a broad spectrum of engagement across various stages of a company's life cycle. Established in 2006 and headquartered in Munich, Germany, the firm possesses a keen interest in backing niche companies, showing an open approach toward all industry sectors. While it broadly considers investments in B2B companies across industrial segments, Blue Cap AG does not confine itself to any specific sector, thereby ensuring a versatile and dynamic investment portfolio. Focusing on the regions of Germany, Austria, and Switzerland, the firm is strategic in its geographical targeting, aiming to leverage its profound understanding of these markets. Financially, Blue Cap AG demonstrates flexibility in its investment approach, with equity investments ranging from $5.65 million to $28.3 million. This is directed at companies having a target sale value between $20 million to $200 million and a maximum EBITD of $10 million, suggesting a focused yet varied investment approach. The company’s methodology of investing from its balance sheet capital further signifies its commitment to the ventures it undertakes, ensuring that it is not just an investor, but a partner in growth.

Products and Services

  • Adhesives & Coatings:
  • Blue Cap AG operates in the Adhesives & Coatings sector, focusing on companies that produce chemical products used for bonding materials together and protecting surfaces. These investments typically revolve around innovative firms that promise to deliver advanced solutions in various industrial and consumer applications, thus driving growth in niche markets.

  • Plastics:
  • In the Plastics segment, Blue Cap AG seeks opportunities within the manufacturing and processing of plastic products. This includes companies that specialize in the production of high-quality plastic materials, components, and finished goods, catering to a broad spectrum of industries such as automotive, medical, and packaging.

  • Business Services:
  • The firm's interest in the Business Services sector encompasses investments in companies that provide B2B services. This could range from consultancy and management services to logistics and supply chain solutions, targeting entities that facilitate operational efficiencies and effectiveness for industrial customers.

  • Medical:
  • Within the Medical segment, Blue Cap AG directs its investments towards companies involved in the health sector, particularly those offering products and services that contribute to medical advancements and patient care. This could involve innovative medical devices, healthcare services, or biotechnological research.

  • Others:
  • Apart from the aforementioned sectors, Blue Cap AG maintains an interest in various other areas without restricting itself to specific sectors. This openness to diverse industries underlines the firm's versatility and commitment to exploring and capitalizing on unique investment opportunities wherever they may arise, particularly within niche markets.

Contact Information

Address: Ludwigstrasse 11
Phone: 49 89 288 9090